KEY FEATURES
| Full Name | Pulmonary Surfactant Associated Protein C |
|---|---|
| Synonym | SFTPC;BRICD6;PSP-C;SFTP2;SMDP2; |
| Assay Type | Sandwich |
| Reactivity | Human |
| Range | 0.31-20ng/mL |
| Sensitivity | 0.19ng/mL |
| Sample Type | Serum,plasma and other biological fluids |
| Sample Volume | 100μL |
| Detection Wavelength | OD450 |
| Transportation Temperature | 2-8°C |
| Specificity | The kit detected Human SPC in the samples and no significant cross-species reactions were found |
| Microplate | 96-wells plate breakable into 12 x 8 wells strip |
TEST PRINCIPLE
| This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human SPC. Standards or samples are added to the micro ELISA plate wells and combined with the specific antibody. Then a biotinylated detection antibody specific for Human SPC and Avidin-Horseradish Peroxidase (HRP) conjugate are added successively to each micro plate well and incubated. Free components are washed away. The substrate solution is added to each well. Only those wells that contain Human SPC, biotinylated detection antibody and Avidin-HRP conjugate will appear blue in color. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human SPC. You can calculate the concentration of Human SPC in the samples by comparing the OD of the samples to the standard curve. |
ELISA KIT COMPONENTS
Upon receipt, unpack promptly and store as recommended in the instructions.
| Components | Specifications | Storage and Notes |
|---|---|---|
| Micro Plate | 96T: 8 wells×12 strips 48T: 8 wells×6 strips | Unopened: -20°C, 12 months Unused: Put it back in the aluminum foil bag and seal it, store it at -20°C. |
| Reference Standard | 96T: 2 vials 48T: 1 vial | Unopened: -20°C, 12 months Please use freshly dissolved standards for each experiment. Discard any unused standards after dissolution. |
| Biotinylated Detection Ab Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C, 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| HRP Conjugate Concentrate (100×) | 96T: 120μL×1 vial 48T: 60μL×1 vial | Unopened: -20°C(Protect from light), 12 months Unused: Please seal the concentrate and store it at -20°C, and discard the working solution. |
| Biotinylated Detection Ab Diluent | 14mL×1 | 2-8℃, 12 months |
| HRP Conjugate Diluent | 14mL×1 | 2-8℃, 12 months |
| Reference Standard & Sample Diluent | 20mL×1 | 2-8℃, 12 months |
| Washing Buffer Concentrate (25×) | 30mL×1 | 2-8℃, 12 months |
| Substrate Reagent(TMB) | 10mL×1 | 2-8°C(Protect from light),12 months |
| Stop Solution | 7mL×1 | 2-8°C/Room temperature |
ASSAY PROCEDURES

TYPICAL DATA

Human SPC ELISA Standard Curve
Typical data are for reference only and curves should be replotted for each experiment. The Logistics function is recommended for fitting.
PRECISION
Intra-Assay Precision (Precision within an assay): Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-Assay Precision (Precision between assays): Three samples of known concentration were tested in twenty separate assays to assess inter-assay precision. Assays were performed by at least three technicians using two lots of components.
| Intra-assay Precision | Inter-assay Precision | |||||
|---|---|---|---|---|---|---|
| Sample | 1 | 2 | 3 | 1 | 2 | 3 |
| n | 20 | 20 | 20 | 20 | 20 | 20 |
| Mean (ng/mL) | 0.92 | 3.16 | 9.43 | 0.9 | 3.36 | 10.08 |
| Standard deviation | 0.06 | 0.16 | 0.42 | 0.06 | 0.14 | 0.41 |
| CV(%) | 6.18 | 5.14 | 4.43 | 6.17 | 4.17 | 4.09 |
RECOVERY
The recovery of Human SPC spiked to three different levels in samples throughout the range of the assay in various matrices was evaluated.
| Sample Type | Range (%) | Average Recovery (%) |
|---|---|---|
| Serum(n=8) | 92-103 | 97 |
| EDTA plasma (n=8) | 90-104 | 97 |
| Cell culture media (n=8) | 91-107 | 99 |
LINEARITY
To assess the linearity of the assay, samples containing and/or spiked with high concentrations of Human SPC in various matrices were diluted with the Reference Standard & Sample Diluent to produce samples with values within the dynamic range of the assay.

Products associated with SPC ELISA Kits
| ABCA3 ELISA Kit | publications with SPC and ABCA3 |
| SFTPB ELISA Kit | publications with SPC and SFTPB |
| SCGB1A1 ELISA Kit | publications with SPC and SCGB1A1 |
| AQP5 ELISA Kit | publications with SPC and AQP5 |
| SFTPA2 ELISA Kit | publications with SPC and SFTPA2 |
| NKX2-1 ELISA Kit | publications with SPC and NKX2-1 |
| SFTPA1 ELISA Kit | publications with SPC and SFTPA1 |
| SFTPD ELISA Kit | publications with SPC and SFTPD |
| DNAJB9 ELISA Kit | publications with SPC and DNAJB9 |
| DNAJC10 ELISA Kit | publications with SPC and DNAJC10 |
Pathways associated with SPC ELISA Kit
| ABC Transporter Disorders Pathway | ABC Transporter Disorders Pathway |
| Circadian Rythm Related Genes Pathway | Circadian Rythm Related Genes Pathway |
| Defective ABCA3 Causes Pulmonary Surfactant Metabolism Dysfunction Type 3 (SMDP3) Pathway | Defective ABCA3 Causes Pulmonary Surfactant Metabolism Dysfunction Type 3 (SMDP3) Pathway |
| Defective CSF2RA Causes Pulmonary Surfactant Metabolism Dysfunction 4 (SMDP4) Pathway | Defective CSF2RA Causes Pulmonary Surfactant Metabolism Dysfunction 4 (SMDP4) Pathway |
| Defective CSF2RB Causes Pulmonary Surfactant Metabolism Dysfunction 5 (SMDP5) Pathway | Defective CSF2RB Causes Pulmonary Surfactant Metabolism Dysfunction 5 (SMDP5) Pathway |
| Defective Pro-SFTPC Causes Pulmonary Surfactant Metabolism Dysfunction 2 (SMDP2) And Respiratory Distress Syndrome (RDS) Pathway | Defective Pro-SFTPC Causes Pulmonary Surfactant Metabolism Dysfunction 2 (SMDP2) And Respiratory Distress Syndrome (RDS) Pathway |
| Disease Pathway | Disease Pathway |
| Diseases Associated With Surfactant Metabolism Pathway | Diseases Associated With Surfactant Metabolism Pathway |
| Diseases Of Metabolism Pathway | Diseases Of Metabolism Pathway |
| Disorders Of Transmembrane Transporters Pathway | Disorders Of Transmembrane Transporters Pathway |
Diseases associated with SPC ELISA Kit
| Lung Diseases | publications with SPC and Lung Diseases |
| Fibrosis | publications with SPC and Fibrosis |
| Pulmonary Fibrosis | publications with SPC and Pulmonary Fibrosis |
| Lung Injury | publications with SPC and Lung Injury |
| Pneumonia | publications with SPC and Pneumonia |
| Idiopathic Pulmonary Fibrosis | publications with SPC and Idiopathic Pulmonary Fibrosis |
| Inflammation | publications with SPC and Inflammation |
| Lung Neoplasms | publications with SPC and Lung Neoplasms |
| Hyperplasia | publications with SPC and Hyperplasia |
| Necrosis | publications with SPC and Necrosis |
Organs/Tissues associated with SPC ELISA Kit
| Lung | publications with SPC and Lung |
| Heart | publications with SPC and Heart |
| Kidney | publications with SPC and Kidney |
| Brain | publications with SPC and Brain |
| Intestine | publications with SPC and Intestine |
| Connective Tissue | publications with SPC and Connective Tissue |
| Ovary | publications with SPC and Ovary |
| Nerve | publications with SPC and Nerve |
| Eye | publications with SPC and Eye |